DGX - Quest Diagnostics Incorporated

NYSE - Nasdaq Real Time Price. Currency in USD

Quest Diagnostics Incorporated

500 Plaza Drive
Secaucus, NJ 07094
United States
973 520 2700

IndustryDiagnostics & Research
Full Time Employees45,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Stephen H. RusckowskiChairman, Pres & CEO2.75MN/A1957
Mr. Mark J. GuinanExec. VP & CFO1.13MN/A1962
Ms. Catherine T. DohertySr. VP and Group Exec. of Clinical Franchise Solutions & Marketing1.01M1.55M1963
Mr. James E. DavisExec. VP of Gen. Diagnostics1.05MN/A1963
Ms. Carrie Eglinton MannerSr. VP of Advanced DiagnosticsN/AN/A1975
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company's Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, gene-based and esoteric testing, anatomic pathology, and other diagnostic information services. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. Its Diagnostic Solutions segment offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Corporate Governance

Quest Diagnostics Incorporated’s ISS Governance QualityScore as of October 1, 2018 is 4. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 4; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.